BIO
Andrea
Redd
Associate Vice President, Global Regulatory Affairs, Drug Delivery & Combination Products
Eli Lilly
Andrea Redd is the current Associate Vice President of the Global Drug Delivery and Device regulatory affairs team at Eli Lilly headquartered in Indianapolis, Indiana. With over 24 years of experience in the pharmaceutical industry, Andrea has held multiple positions in R&D, project management, and regulatory affairs, with a primary focus on the CMC aspects of drug development for both generic and new drug product submissions. She transitioned into combination products in 2014 and her expertise in both drug and device regulations has enabled her to successfully bridge the gaps that are often seen when a company that is heavily focused on drug product development enters into the combination product space.